Skip to main content
Erschienen in: American Journal of Clinical Dermatology 5/2002

01.08.2002 | Review Article

Complementary/Alternative Medicine in Dermatology

Evidence-Assessed Efficacy of Two Diseases and Two Treatments

verfasst von: Professor Edzard Ernst, Max H. Pittler, Clare Stevinson

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 5/2002

Einloggen, um Zugang zu erhalten

Abstract

The objective of this article is to provide a brief, but critical, overview of the evidence related to complementary/ alternative medicine (CAM) use, and to offer valid and useful information for dermatologists in clinical practice. Systematic literature searches were conducted on these databases: Medline, EMBASE, The Cochrane Library, CISCOM and AMED (until October 2000). Where appropriate, the evaluation of the published literature was based on systematic reviews and randomized controlled trials. After scanning the literature it was decided to focus on a selection of two conditions (atopic dermatitis and chronic venous insufficiency) and two treatment modalities (aloe vera gel and tea tree oil). Data for the life-time prevalence of CAM use by patients with dermatological disease ranges between 35 to 69%. The most popular modalities include herablism and (other) dietary supplements, while atopic dermatitis is one of the conditions most frequently treated with CAM. For patients with atopic dermatitis the evidence relates to autogenic training, hypnotherapy, diet, herbal medicine, and dietary supplements. Compelling evidence of effectiveness exists for none of these therapies. However, some promising data have been reported for those with a psychological component: autogenic training, biofeedback and hypnotherapy. For chronic venous insufficiency there is relatively convincing evidence for the effectiveness of oral horse chestnut seed extract. The data for aloe vera gel and tea tree oil indicate that for neither is there compelling evidence of effectiveness. The use of CAM treatments is not free of risk; direct and indirect risks associated with CAM must be considered.
Literatur
1.
Zurück zum Zitat Eisenberg D., David R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990–1997. JAMA 1998; 280: 1569–1575PubMedCrossRef Eisenberg D., David R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990–1997. JAMA 1998; 280: 1569–1575PubMedCrossRef
2.
Zurück zum Zitat Ernst E., White A.R. The BBC survey of complementary medicine use in the UK. Complement Ther Med 2000; 8: 32–36PubMed Ernst E., White A.R. The BBC survey of complementary medicine use in the UK. Complement Ther Med 2000; 8: 32–36PubMed
3.
Zurück zum Zitat Ernst E. The usage of complementary therapies by dermatological patients: a systematic review. Br J Dermatol 2000; 142: 857–861PubMedCrossRef Ernst E. The usage of complementary therapies by dermatological patients: a systematic review. Br J Dermatol 2000; 142: 857–861PubMedCrossRef
4.
Zurück zum Zitat Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol 1990; 70: 421–424PubMed Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol 1990; 70: 421–424PubMed
5.
Zurück zum Zitat Fleischer A.B., Feldman S.R., Rapp S.R., et al. Alternative therapies commonly used within a population of patients with psoriasis. Cutis 1996; 158: 216–220 Fleischer A.B., Feldman S.R., Rapp S.R., et al. Alternative therapies commonly used within a population of patients with psoriasis. Cutis 1996; 158: 216–220
6.
Zurück zum Zitat Söllner W., Zingg-Schir M., Rumpold G., et al. Attitude towards alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol 1997; 133: 316–321PubMedCrossRef Söllner W., Zingg-Schir M., Rumpold G., et al. Attitude towards alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol 1997; 133: 316–321PubMedCrossRef
7.
Zurück zum Zitat Ramos-Remus C., Gamez-Nava J.I., Gonzalez-Lopez L, et al. Use of alternative medicine in a consecutive sample of patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 2490–2491PubMed Ramos-Remus C., Gamez-Nava J.I., Gonzalez-Lopez L, et al. Use of alternative medicine in a consecutive sample of patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 2490–2491PubMed
8.
Zurück zum Zitat Berg M., Arnetz B. Characteristics of users and nonusers of alternative medicine in dermatologic patients attending a university hospital clinic: a short report. J Altern Complement Med 1998; 4: 277–279PubMedCrossRef Berg M., Arnetz B. Characteristics of users and nonusers of alternative medicine in dermatologic patients attending a university hospital clinic: a short report. J Altern Complement Med 1998; 4: 277–279PubMedCrossRef
9.
Zurück zum Zitat Clark C.M., McKay R.A., Fortune D.G., et al. Use of alternative treatments by patients with psoriasis. Br J Gen Pract 1998; 48: 1873–1874PubMed Clark C.M., McKay R.A., Fortune D.G., et al. Use of alternative treatments by patients with psoriasis. Br J Gen Pract 1998; 48: 1873–1874PubMed
10.
Zurück zum Zitat Augustin M., Zschocke I., Buhrke U. Attitudes and prior experience with respect to alternative medicine among dermatological patients: the Freiburg Questionnaire on Attitudes to Naturopathy (FAN). Forsch Komplementärmed 1999; 6: 26–29PubMed Augustin M., Zschocke I., Buhrke U. Attitudes and prior experience with respect to alternative medicine among dermatological patients: the Freiburg Questionnaire on Attitudes to Naturopathy (FAN). Forsch Komplementärmed 1999; 6: 26–29PubMed
11.
Zurück zum Zitat Ehlers A., Stangier U., Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol 1995; 63: 624–635PubMedCrossRef Ehlers A., Stangier U., Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol 1995; 63: 624–635PubMedCrossRef
12.
Zurück zum Zitat Lever R., MacDonald C., Waugh P., et al. Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol 1998; 9: 13–19PubMedCrossRef Lever R., MacDonald C., Waugh P., et al. Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol 1998; 9: 13–19PubMedCrossRef
13.
Zurück zum Zitat Atherton D.J., Sewall M., Soothill J.F., et al. A double-blind controlled cross-over trial of an antigen-avoidance diet in atopic eczema. Lancet 1978; 25: 401–403CrossRef Atherton D.J., Sewall M., Soothill J.F., et al. A double-blind controlled cross-over trial of an antigen-avoidance diet in atopic eczema. Lancet 1978; 25: 401–403CrossRef
14.
Zurück zum Zitat Neild V.S., Marsden R.A., Bailes J.A., et al. Egg and mild exclusion diets in atopic eczema. Br J Dermatol 1986; 114: 117–123PubMedCrossRef Neild V.S., Marsden R.A., Bailes J.A., et al. Egg and mild exclusion diets in atopic eczema. Br J Dermatol 1986; 114: 117–123PubMedCrossRef
15.
Zurück zum Zitat Cant A.J., Bailes J.A., Marsden R.A., et al. Effect of maternal dietary exclusion on breast fed infants with eczema: two controlled studies. BMJ 1986; 293: 231–233PubMedCrossRef Cant A.J., Bailes J.A., Marsden R.A., et al. Effect of maternal dietary exclusion on breast fed infants with eczema: two controlled studies. BMJ 1986; 293: 231–233PubMedCrossRef
16.
Zurück zum Zitat Kramer M.S. Maternal antigen avoidance during pregnancy for preventing atopic disease in infants of women at high risk (Cochrane Review). Available in The Cochrane Library [database on CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2002 Kramer M.S. Maternal antigen avoidance during pregnancy for preventing atopic disease in infants of women at high risk (Cochrane Review). Available in The Cochrane Library [database on CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2002
17.
Zurück zum Zitat Kramer M.S. Maternal antigen avoidance during lactation for preventing atopic disease in infants of women at high risk (Cochrane Review). Available in The Cochrane Library [database on CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2002 Kramer M.S. Maternal antigen avoidance during lactation for preventing atopic disease in infants of women at high risk (Cochrane Review). Available in The Cochrane Library [database on CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2002
18.
Zurück zum Zitat Baslau M., Thaci D. Atopic dermatitis: borage oil for systemic therapy. Zeitschr Dermatol 1996; 182: 131–136 Baslau M., Thaci D. Atopic dermatitis: borage oil for systemic therapy. Zeitschr Dermatol 1996; 182: 131–136
19.
Zurück zum Zitat Henz B.M., Jablonska S., Van de Kerkhof P.C.M., et al. Double blind, multicentre analysis of the efficacy of borage oil or patients with atopic eczema. Br J Dermatol 1999; 140: 685–688PubMedCrossRef Henz B.M., Jablonska S., Van de Kerkhof P.C.M., et al. Double blind, multicentre analysis of the efficacy of borage oil or patients with atopic eczema. Br J Dermatol 1999; 140: 685–688PubMedCrossRef
20.
Zurück zum Zitat Borreck S., Hildebrandt A., Forster J. Borage seed oil and atopic dermatitis. Klinische Pädiatrie 1997; 209: 100–104CrossRef Borreck S., Hildebrandt A., Forster J. Borage seed oil and atopic dermatitis. Klinische Pädiatrie 1997; 209: 100–104CrossRef
21.
Zurück zum Zitat Armstrong N., Ernst E. Treatment of eczema with Chinese herbs: a systematic review of randomised clinical trials. Br J Clin Pharmacol 1999; 48: 262–264PubMedCrossRef Armstrong N., Ernst E. Treatment of eczema with Chinese herbs: a systematic review of randomised clinical trials. Br J Clin Pharmacol 1999; 48: 262–264PubMedCrossRef
22.
Zurück zum Zitat Fung A.Y., Look P.C., Chong L.Y., et al. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999; 38: 387–392PubMedCrossRef Fung A.Y., Look P.C., Chong L.Y., et al. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999; 38: 387–392PubMedCrossRef
23.
Zurück zum Zitat Morse P.F., Horrobin D.R., Manku M.S., et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema: relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol 1989; 121: 75–90PubMedCrossRef Morse P.F., Horrobin D.R., Manku M.S., et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema: relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol 1989; 121: 75–90PubMedCrossRef
24.
Zurück zum Zitat Berth-Jones J., Brown G. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993; 341: 1557–1560PubMedCrossRef Berth-Jones J., Brown G. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993; 341: 1557–1560PubMedCrossRef
25.
Zurück zum Zitat Biagi P.L., Bordini A., Hrelia S., et al. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res 1994; 20: 77–84PubMed Biagi P.L., Bordini A., Hrelia S., et al. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res 1994; 20: 77–84PubMed
26.
Zurück zum Zitat Whitaker D.K., Cilliers J., de Beer C. Evening primrose oil (Epogam) in the treatment of chronic hand dermatitis: disappointing therapeutic results. Dermatology 1996; 193: 115–120PubMedCrossRef Whitaker D.K., Cilliers J., de Beer C. Evening primrose oil (Epogam) in the treatment of chronic hand dermatitis: disappointing therapeutic results. Dermatology 1996; 193: 115–120PubMedCrossRef
27.
Zurück zum Zitat Hederos C.A., Berg A. Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Childhood 1996; 75: 494–497CrossRef Hederos C.A., Berg A. Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Childhood 1996; 75: 494–497CrossRef
28.
Zurück zum Zitat Sokel B., Christie D., Kent A., et al. A comparison of hypnotherapy and biofeedback in the treatment of childhood atopic eczema. Contemp Hypnosis 1993; 10: 145–154 Sokel B., Christie D., Kent A., et al. A comparison of hypnotherapy and biofeedback in the treatment of childhood atopic eczema. Contemp Hypnosis 1993; 10: 145–154
29.
Zurück zum Zitat Fairris G.M., Perkins P.J., Lloyd B., et al. The effect of atopic dermatitis of supplementation with selenium and vitamin E. Acta Derm Venerol 1989; 69: 359–362PubMed Fairris G.M., Perkins P.J., Lloyd B., et al. The effect of atopic dermatitis of supplementation with selenium and vitamin E. Acta Derm Venerol 1989; 69: 359–362PubMed
30.
Zurück zum Zitat Ewing C.I., Gibbs A.C., Ashcroft C., et al. Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr 1991; 45: 507–510PubMed Ewing C.I., Gibbs A.C., Ashcroft C., et al. Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr 1991; 45: 507–510PubMed
31.
Zurück zum Zitat Ihme N., Kiesewetter H., Jung F., et al. Leg edema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single blind, randomised, placebo-controlled clinical trial. Eur J Clin Pharmacol 1996; 50: 443–447PubMedCrossRef Ihme N., Kiesewetter H., Jung F., et al. Leg edema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single blind, randomised, placebo-controlled clinical trial. Eur J Clin Pharmacol 1996; 50: 443–447PubMedCrossRef
32.
Zurück zum Zitat Rudofsky G., Diehm C., Gruß J.D., et al. Chronisch venöse insuffizienz. Münch Med Wschr 1990; 132: 205–210 Rudofsky G., Diehm C., Gruß J.D., et al. Chronisch venöse insuffizienz. Münch Med Wschr 1990; 132: 205–210
33.
Zurück zum Zitat Weindorf N., Schultz-Ehrenburg U. Kontrollierte Studie zur oralen Venentonisierung der primären Varikosis mit Ruscus aculeatus und Trimethylherperidinchalkon. Z Hautkr 1987; 62: 28–38PubMed Weindorf N., Schultz-Ehrenburg U. Kontrollierte Studie zur oralen Venentonisierung der primären Varikosis mit Ruscus aculeatus und Trimethylherperidinchalkon. Z Hautkr 1987; 62: 28–38PubMed
34.
Zurück zum Zitat Cappelli R., Nicora M., Di Perri T. Use of extract of ruscus aculeatus in venous disease in the lower limbs. Drugs Exp Clin Res 1988; 14: 277–283PubMed Cappelli R., Nicora M., Di Perri T. Use of extract of ruscus aculeatus in venous disease in the lower limbs. Drugs Exp Clin Res 1988; 14: 277–283PubMed
35.
Zurück zum Zitat Janssens D., Michiels C., Guillaume G., et al. Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: protective effect of Ginkgor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 33: 7–11PubMedCrossRef Janssens D., Michiels C., Guillaume G., et al. Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: protective effect of Ginkgor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 33: 7–11PubMedCrossRef
36.
Zurück zum Zitat Cesarone M.R., Laurora G., De Sanctis M.T., et al. The microcirculatory activity of Centella asiatica in venous insufficiency: a double-blind study. Minerva Cardioangiol 1994; 42: 299–304PubMed Cesarone M.R., Laurora G., De Sanctis M.T., et al. The microcirculatory activity of Centella asiatica in venous insufficiency: a double-blind study. Minerva Cardioangiol 1994; 42: 299–304PubMed
37.
Zurück zum Zitat Pointel J.P., Bocaalon H., Cloarec M., et al. Titrated extract of Centella asiatica (TECA) in the treatment of venous insufficiency of the lower limbs. Angiology 1987; 38: 46–50PubMedCrossRef Pointel J.P., Bocaalon H., Cloarec M., et al. Titrated extract of Centella asiatica (TECA) in the treatment of venous insufficiency of the lower limbs. Angiology 1987; 38: 46–50PubMedCrossRef
38.
Zurück zum Zitat Allergra C., Pollari G., Criscuolo A. L’estratto di Centella asiatica nelle flebopatie degli arti iferiori. Clin Ther 1981; 99: 507–513 Allergra C., Pollari G., Criscuolo A. L’estratto di Centella asiatica nelle flebopatie degli arti iferiori. Clin Ther 1981; 99: 507–513
39.
Zurück zum Zitat Pittler M.H., Ernst E. Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Arch Dermatol 1998; 134: 1356–1360PubMedCrossRef Pittler M.H., Ernst E. Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Arch Dermatol 1998; 134: 1356–1360PubMedCrossRef
40.
Zurück zum Zitat Kiesewetter H., Koscielny J., Kalus U., et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II): a randomized, double-blind, placebo-controlled trial. Arzneimittel Forschung 2000; 50: 109–117PubMed Kiesewetter H., Koscielny J., Kalus U., et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II): a randomized, double-blind, placebo-controlled trial. Arzneimittel Forschung 2000; 50: 109–117PubMed
41.
Zurück zum Zitat Ernst E., Saradeth T., Resch K.L. Complementary treatment of varicose veins: a randomized, placebo-controlled, double-blind trial. Phlebology 1990; 5: 157–163 Ernst E., Saradeth T., Resch K.L. Complementary treatment of varicose veins: a randomized, placebo-controlled, double-blind trial. Phlebology 1990; 5: 157–163
42.
Zurück zum Zitat Ernst E., Saradeth T., Resch K.L. A single blind randomized controlled trial of hydrotherapy for varicose veins. Vasa 1991; 20: 147–152PubMed Ernst E., Saradeth T., Resch K.L. A single blind randomized controlled trial of hydrotherapy for varicose veins. Vasa 1991; 20: 147–152PubMed
43.
Zurück zum Zitat Saradeth T., Ernst E., Resch K.L. Hydrotherapy for varicose veins: a randomized, controlled trial. Eur J Phys Med Rehabil 1993; 3: 123–124 Saradeth T., Ernst E., Resch K.L. Hydrotherapy for varicose veins: a randomized, controlled trial. Eur J Phys Med Rehabil 1993; 3: 123–124
44.
Zurück zum Zitat Hartmann B., Drews B., Bassenge E. Effects of bathing in CO2-containing thermal water on the venous hemodynamics of healthy persons with venous diseases. Phys Med Rehabil Kurortmed 1993; 3: 153–157CrossRef Hartmann B., Drews B., Bassenge E. Effects of bathing in CO2-containing thermal water on the venous hemodynamics of healthy persons with venous diseases. Phys Med Rehabil Kurortmed 1993; 3: 153–157CrossRef
45.
Zurück zum Zitat Fetrow C.W., Avila J.R. Complementary and alternative medicines. Philadelphia (PA): Springhouse, 1999 Fetrow C.W., Avila J.R. Complementary and alternative medicines. Philadelphia (PA): Springhouse, 1999
46.
Zurück zum Zitat Pizzorno J.E., Murray M.T. Textbook of natural medicine. Edinburgh: Churchill Livingstone, 1999 Pizzorno J.E., Murray M.T. Textbook of natural medicine. Edinburgh: Churchill Livingstone, 1999
47.
Zurück zum Zitat Vogler B.K., Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999; 49: 823–828PubMed Vogler B.K., Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999; 49: 823–828PubMed
48.
Zurück zum Zitat Fulton J.E. The stimulation of postdermabrasion wound healing with stabilised aloe vera gel-polyethylene oxide dressing. J Dermatol Surg Oncol 1990; 16: 460–467PubMed Fulton J.E. The stimulation of postdermabrasion wound healing with stabilised aloe vera gel-polyethylene oxide dressing. J Dermatol Surg Oncol 1990; 16: 460–467PubMed
49.
Zurück zum Zitat Schmidt J.M., Greenspoon J.S. Aloe vera dermal wound gel is associated with a delay in would healing. Obstet Gynecol 1991; 1: 115–117 Schmidt J.M., Greenspoon J.S. Aloe vera dermal wound gel is associated with a delay in would healing. Obstet Gynecol 1991; 1: 115–117
50.
Zurück zum Zitat Syed T.A., Ahmad S.A., Holt A.H., et al. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health 1996; 1: 505–509PubMedCrossRef Syed T.A., Ahmad S.A., Holt A.H., et al. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health 1996; 1: 505–509PubMedCrossRef
51.
Zurück zum Zitat Williams M.S., Burk M., Loprinzi C.L., et al. Phase III double-blind evaluation of an Aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996; 36: 345–349PubMedCrossRef Williams M.S., Burk M., Loprinzi C.L., et al. Phase III double-blind evaluation of an Aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996; 36: 345–349PubMedCrossRef
52.
Zurück zum Zitat Syed T.A., Cheema K.M., Ashfaq A., et al. Aloe vera extract 0.5 % in a hydrophilic cream versus Aloe vera gel for the management of genital herpes in males: a placebo-controlled, double-blind, comparative study [letter]. J Eur Acad Dermatol Venereal 1996; 7: 294–295 Syed T.A., Cheema K.M., Ashfaq A., et al. Aloe vera extract 0.5 % in a hydrophilic cream versus Aloe vera gel for the management of genital herpes in males: a placebo-controlled, double-blind, comparative study [letter]. J Eur Acad Dermatol Venereal 1996; 7: 294–295
53.
Zurück zum Zitat Syed T.A., Afzal M., Ahmad S.A., et al. Management of genital herpes in men with 0.5% Aloe vera extract in a hydrophylic cream: a placebo-controlled doubleblind study. J Dermatol Treat 1997; 8: 99–102CrossRef Syed T.A., Afzal M., Ahmad S.A., et al. Management of genital herpes in men with 0.5% Aloe vera extract in a hydrophylic cream: a placebo-controlled doubleblind study. J Dermatol Treat 1997; 8: 99–102CrossRef
54.
Zurück zum Zitat Ernst E., Huntley A. Tea tree oil: a systematic review of randomized clinical trials. Forsch Komplementärmed 2000; 7: 17–20CrossRef Ernst E., Huntley A. Tea tree oil: a systematic review of randomized clinical trials. Forsch Komplementärmed 2000; 7: 17–20CrossRef
55.
Zurück zum Zitat Bassett I.B., Pannowitz D.L., Barnetson R. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990; 153: 455–458PubMed Bassett I.B., Pannowitz D.L., Barnetson R. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990; 153: 455–458PubMed
56.
Zurück zum Zitat Tong M.M., Altman P.M., Baretson R. Tea tree oil in the treatment of tinea pedis. Aust J Dermatol 1992; 33: 145–149CrossRef Tong M.M., Altman P.M., Baretson R. Tea tree oil in the treatment of tinea pedis. Aust J Dermatol 1992; 33: 145–149CrossRef
57.
Zurück zum Zitat Buck D.S., Nidorf D.M., Addino J.G. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract 1994; 38: 601–605PubMed Buck D.S., Nidorf D.M., Addino J.G. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract 1994; 38: 601–605PubMed
58.
Zurück zum Zitat Syed T.A., Qureshi Z.A., Ali S.M., et al. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health 1999; 4: 284–287PubMedCrossRef Syed T.A., Qureshi Z.A., Ali S.M., et al. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health 1999; 4: 284–287PubMedCrossRef
59.
60.
Zurück zum Zitat Davies E.G., Pollock I., Steel H.M. Chinese herbs for eczema [letter]. Lancet 1990; 336: 177 Davies E.G., Pollock I., Steel H.M. Chinese herbs for eczema [letter]. Lancet 1990; 336: 177
61.
62.
Zurück zum Zitat MacGregor F.B., Abernethy V.E., Dahabra S., et al. Hepatotoxicity of herbal remedies. BMJ 1989; 229: 1156–1157CrossRef MacGregor F.B., Abernethy V.E., Dahabra S., et al. Hepatotoxicity of herbal remedies. BMJ 1989; 229: 1156–1157CrossRef
64.
Zurück zum Zitat Ferguson J.E., Chalmers F.J.G., Rowlands D.J. Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine. Br J Dermatol 1997; 136: 592–593PubMedCrossRef Ferguson J.E., Chalmers F.J.G., Rowlands D.J. Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine. Br J Dermatol 1997; 136: 592–593PubMedCrossRef
65.
Zurück zum Zitat Shaw D., Leon C., Kolev S. Traditional remedies and food supplements: a 5-year toxicological study (1991–1995). Drug Saf 1997; 17: 342–356PubMedCrossRef Shaw D., Leon C., Kolev S. Traditional remedies and food supplements: a 5-year toxicological study (1991–1995). Drug Saf 1997; 17: 342–356PubMedCrossRef
66.
Zurück zum Zitat Lord G.M., Tagore R., Cook T., et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354: 481–482PubMedCrossRef Lord G.M., Tagore R., Cook T., et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354: 481–482PubMedCrossRef
67.
Zurück zum Zitat Koo J., Arian S. Traditional Chinese medicine for the treatment of dermatologic disorders. Arch Dermatol 1998; 134: 1388–1393PubMedCrossRef Koo J., Arian S. Traditional Chinese medicine for the treatment of dermatologic disorders. Arch Dermatol 1998; 134: 1388–1393PubMedCrossRef
68.
Zurück zum Zitat Ernst E. Risks associated with complementary therapies. In: Dukes M.N.G., Aronson J.K., editors. Meyler’s side effects of drugs. 14th ed. Amsterdam: Elsevier Science, 2000: 1649–1681 Ernst E. Risks associated with complementary therapies. In: Dukes M.N.G., Aronson J.K., editors. Meyler’s side effects of drugs. 14th ed. Amsterdam: Elsevier Science, 2000: 1649–1681
69.
Zurück zum Zitat Ernst E., Hentschel C.H. Diagnostic methods in complementary medicine: which craft is witchcraft? Int J Risk Safety Med 1995; 7: 55–63 Ernst E., Hentschel C.H. Diagnostic methods in complementary medicine: which craft is witchcraft? Int J Risk Safety Med 1995; 7: 55–63
70.
Zurück zum Zitat Ernst E., Pittler M.H., Stevinson C., et al. The desktop guide to complementary and alternative medicine. Edinburgh: Mosby, 2001 Ernst E., Pittler M.H., Stevinson C., et al. The desktop guide to complementary and alternative medicine. Edinburgh: Mosby, 2001
Metadaten
Titel
Complementary/Alternative Medicine in Dermatology
Evidence-Assessed Efficacy of Two Diseases and Two Treatments
verfasst von
Professor Edzard Ernst
Max H. Pittler
Clare Stevinson
Publikationsdatum
01.08.2002
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 5/2002
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200203050-00006

Weitere Artikel der Ausgabe 5/2002

American Journal of Clinical Dermatology 5/2002 Zur Ausgabe

Leading Article

Self-Tanning Lotions

Current Opinion

Vitiligo

Therapy in Practice

Cutaneous Tuberculosis

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.